Herbal Lozenges in Pharyngitis
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: J029- Acute pharyngitis, unspecified
- Registration Number
- CTRI/2023/05/052495
- Lead Sponsor
- Parul Institute of Ayurved
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient presenting with sign and symptoms of Pharyngitis
Exclusion Criteria
Patient who is not willing for the trial
Patient who is under other treatment modalities Known cases of adenoids and sinusitis
Known cases of carcinoma of pharynx
Known cases of herpes simplex 1&2herpes zoster thrush syphilitic pharyngitis diphtheroid pharyngitis HIV-1 & 2 tubercular pharyngitis peritonsillar abscess and other specific and complicated cases of pharyngitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relieve from primary symptoms of pharyngitisTimepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Relieve from Throat pain & other symptoms of vrunda <br/ ><br>Timepoint: 2 weeks
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Vrunda herbal lozenges' efficacy in acute pharyngitis (CTRI/2023/05/052495)?
How do Vrunda herbal lozenges compare to NSAIDs/antibiotics in Phase III trials for J029 acute pharyngitis?
Which inflammatory biomarkers correlate with response to Vrunda lozenges in pharyngitis patients (CTRI/2023/05/052495)?
What adverse events are reported for Vrunda herbal lozenges versus conventional pharyngitis therapies in clinical studies?
Are there synergistic herbal combinations or Ayurvedic drug classes targeting pharyngitis alongside Vrunda lozenges (CTRI/2023/05/052495)?